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present study, we demonstrate that poly(gA) c9rAN pro-
teins are neurotoxic and may be implicated in the neuro-
degenerative processes of c9FTD/AlS. Specifically, we 
show that expression of poly(gA) proteins in cultured cells 
and primary neurons leads to the formation of soluble and 
insoluble high molecular weight species, as well as inclu-
sions composed of filaments similar to those observed in 
c9FTD/AlS brain tissues. The expression of poly(gA) 
proteins is accompanied by caspase-3 activation, impaired 
neurite outgrowth, inhibition of proteasome activity, and 
evidence of endoplasmic reticulum (er) stress. Of impor-
tance, er stress inhibitors, salubrinal and TUDCA, pro-
vide protection against poly(gA)-induced toxicity. Taken 
together, our data provide compelling evidence towards 
establishing rAN translation as a pathogenic mechanism 
of c9FTD/AlS, and suggest that targeting the er using 
small molecules may be a promising therapeutic approach 
for these devastating diseases.
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Introduction
Frontotemporal dementia (FTD) and amyotrophic lateral 
sclerosis (AlS) are devastating neurodegenerative disor-
ders. Despite the fact that FTD presents with changes in 
behavior, personality and language and AlS is a motor 
neuron disease which leads to progressive paralysis, 
there is genetic, neuropathological and clinical overlap 
between them. Not only do FTD and AlS frequently 
occur in the same family, many AlS patients develop 
Abstract The occurrence of repeat-associated non-
ATg (rAN) translation, an atypical form of translation of 
expanded repeats that results in the synthesis of homopoly-
meric expansion proteins, is becoming more widely appre-
ciated among microsatellite expansion disorders. Such 
disorders include amyotrophic lateral sclerosis and fron-
totemporal dementia caused by a hexanucleotide repeat 
expansion in the C9ORF72 gene (c9FTD/AlS). We and 
others have recently shown that this bidirectionally tran-
scribed repeat is rAN translated, and the “c9rAN pro-
teins” thusly produced form neuronal inclusions through-
out the central nervous system of c9FTD/AlS patients. 
Nonetheless, the potential contribution of c9rAN proteins 
to disease pathogenesis remains poorly understood. In the 
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FTD-like cognitive and behavioral impairments [22, 39, 
54], and as many as half of FTD patients develop motor 
neuron dysfunction [39]. Neuropathologically, neu-
ronal and glial inclusions of TDP-43 are found in most 
AlS cases, as well as in the most common pathologi-
cal subtype of FTD [frontotemporal lobar degeneration 
with TDP-43 pathology (FTlD-TDP)]. Because of this 
overlap, AlS and FTlD-TDP are considered part of a 
disease spectrum. This concept was recently reinforced 
with the discovery that a g4C2·g2C4 repeat expansion in 
a non-coding region of the C9ORF72 gene is the most 
common genetic cause of AlS and FTlD-TDP [14, 41, 
58].
How the repeat expansion in C9ORF72 causes 
“c9FTD/AlS” is not yet definitively known, but many 
advances have been made since the discovery of this 
mutation in 2011 (see [21] for review). Potential mecha-
nisms include loss of C9OrF72 function due to epige-
netic changes resulting in decreased C9ORF72 mrNA 
expression [5, 73]. In addition, repeat-containing rNAs 
bidirectionally transcribed from the expanded repeat are 
thought to contribute to disease pathogenesis. The bind-
ing of these transcripts by various rNA-binding proteins 
(rBPs) may impair the ability of these rBPs to interact 
with their respective rNA targets. Because the repeat-con-
taining transcripts form nuclear rNA foci, rBPs that bind 
these transcripts may be sequestered therein, also resulting 
in their loss of function. Furthermore, we and others have 
shown that transcripts of expanded g4C2 and g2C4 repeats 
undergo repeat-associated non-ATg (rAN) translation [3, 
20, 43, 44, 78], an unconventional mode of translation that 
occurs in the absence of an initiating ATg and in all pos-
sible reading frames, first described by ranum and col-
leagues [77]. rAN translation of expanded g4C2 and g2C4 
repeats leads to the synthesis of 6 “c9rAN proteins” of 
repeating dipeptides: poly(gA) and poly(gr) from sense 
g4C2 repeats, poly(Pr) and poly(PA) from antisense g2C4 
repeats, and poly(gP) proteins from both sense and anti-
sense transcripts.
Neuronal inclusions of c9rAN proteins are now con-
sidered a hallmark of c9FTD/AlS. While this implicates 
rAN translation as a mechanism of disease, confirma-
tory data are lacking. The ranum group has shown that 
poly(Pr) and poly(gP) proteins induce cellular toxicity 
in cultured cells independently of the accumulation of 
rNA foci [78], suggesting that c9rAN protein expres-
sion may indeed be detrimental. However, given that 
inclusions of poly(gP) proteins are present in some, but 
not all, affected regions of the central nervous system 
(CNS) in c9FTD/AlS [3, 20], and a recent study show-
ing that poly(gA) pathology, unlike TDP-43 pathology, 
does not correlate with the degree of neurodegeneration 
in c9FTD/AlS [40], put into question the contribution of 
c9rAN proteins to disease pathogenesis. Conversely, the 
discovery of a c9FTD kindred with early intellectual dis-
ability and extensive poly(gA) inclusions but little, if any, 
TDP-43 pathology [56], provides compelling evidence that 
c9rAN proteins, or at least poly(gA) proteins, are harm-
ful. like poly(gP) inclusions, inclusions of poly(gA) 
appear to be abundant in c9FTD/AlS [37, 40, 43, 44, 56], 
perhaps because of the hydrophobic nature of the pro-
tein. Using various models, the present study thus sought 
to evaluate the neurotoxic potential of poly(gA) protein 




To generate expression vectors for gFP-(gA)50, gFP-
(gP)47, gFP-(gr)50, gFP-(Pr)50 or gFP-(PA)50, gene 
fragments containing individual dipeptide repeats 
(Table 1) were synthesized by geneArt and ligated to the 
HindIII and BamHI restriction sites of a pegFP-C1 vec-
tor (Clontech laboratories) in frame with the egFP cod-
ing sequence. To generate the AAV1-gFP-(gA)50 expres-
sion vector, the egFP coding sequence with restriction 
sites identical to those in pegFP-C1 and containing 
a stop codon in each frame downstream of the multiple 
cloning site was cloned into the AAV expression vector 
pAM/CBA-pl-WPre-BgH (“pAAV”). gene fragments 
from the gene synthesis were cloned into the HindIII and 
BamHI restriction sites of the pAAV egFP fusion vec-
tor in frame with the egFP coding sequence. To generate 
the gST-(gA)50 vector, PCr was performed to synthe-
size cDNA of a (gA)50 fragment, which was then inserted 
into a pgeX-6P-1 vector (ge Healthcare) using BamHI 
and XhoI cloning sites. To generate the ATg-(gA)50-V5 
vector, cDNA of the (gA)50 fragment with an ATg start 
codon was inserted into a pcDNA6-V5-His vector (life 
Technologies) using HindIII and XhoI cloning sites. To 
generate the gFP-c9(gA)50 expression vector, a gene 
fragment containing 50 pathological g4C2 repeats was 
produced as previously described [33], and then ligated to 
ecorV restriction sites of a pcDNA6-V5-His vector (life 
Technologies). The gFP sequence was inserted upstream 
of (g4C2)50 using HindIII and ecorI cloning sites to drive 
protein expression in the gA reading frame. To generate 
pAg3-6 × stops-(±)ATg-(gA)50-3T vectors, cDNA of 
the (gA)50 fragment with or without an ATg start codon 
was inserted in a pAg3-6 × stops-3T vector between 
the 6 stop codons and the 3 tags (Online resource 4a). 
The sequence of all plasmids was verified by sequence 
analysis.
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Purification of recombinant proteins and generation 
of anti-poly(gA) antibody
gST or gST-(gA)50 plasmids were used for transforma-
tion in rosetta™(De3)plysS competent cells (eMD4Bio-
sciences). To induce expression of recombinant proteins, 
bacteria were cultured overnight at 16 °C in the presence 
of 0.5 mM isopropyl β-d-1-thiogalactopyranoside (IPTg). 
After centrifugation, the bacteria pellet was washed with 
phosphate-buffered saline (PBS), and then lysed on ice for 
30 min with PBS containing 1 % Triton X-100 (PBST). 
After sonication, the lysates were centrifuged at 18,000g 
for 30 min. The resulting supernatant was applied to a 
glutathione Sepharose 4B column (ge Healthcare). After 
washing the column with PBST, the recombinant proteins 
were eluted from the column using Tris–HCl (50 mM, 
pH 8.0) containing 20 mM reduced glutathione. After-
wards, the solution was dialyzed with 50 mM Tris–HCl 
(50 mM, pH 8.0) to remove glutathione, and then con-
centrated. recombinant gST-(gA)50 protein was used as 
the antigen to produce rabbit polyclonal antibodies. Pre-
immune serum from rabbits was tested against brain tis-
sue from c9FTD/AlS cases by immunohistochemistry and 
confirmed negative. Antiserum was used directly for West-
ern blot and immunohistochemistry studies.
Immunohistochemistry and semi-quantitative analysis 
of poly(gA) inclusions in c9FTD/AlS
Neuropathological assessment was performed on 10 
cases with the expanded C9ORF72 hexanucleotide 
repeat. These cases were neuropathologically diagnosed 
as frontotemporal lobar degeneration (FTlD; N = 4), 
amyotrophic lateral sclerosis (AlS; N = 4), or both 
(FTlD–MND; N = 2). Four regions of formalin-fixed 
paraffin-embedded tissue from the left hemi-brain were 
selected: the midfrontal gyrus of the frontal lobe, the pos-
terior hippocampus at the level of the lateral geniculate 
nucleus (including occipitotemporal gyrus), the thalamus 
at the level of the subthalamic nucleus, and the cerebellum 
Table 1  Synthetic cDNA 
sequences used for expression 
vectors



































The target sequence of the 
FISH probe for the synthetic 
(gA)50 sequence is highlighted 
in yellow
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with the dentate nucleus. Tissue was cut into 6-µm-thick 
sections, mounted on glass slides, and dried overnight. 
Slides were subsequently deparaffinized and immuno-
histochemistry was performed using 30 min of antigen 
retrieval (steam), Dako enVision+ reagents and Auto-
stainer (DAKO), and the anti-poly(gA) rabbit polyclonal 
antibody (1:50,000). Following immunohistochemistry, 
all slides were counterstained with lerner’s hematoxylin, 
dehydrated, and coverslipped. Slides were analyzed semi-
quantitatively (Table 2) on an Olympus BX40 micro-
scope (Olympus America). Neuropathologic burden was 
graded on a 4-point scale: sparse (±), mild (+), moderate 
(++), and severe (+++). In densely neuronal-populated 
regions, such as the internal granule cell layer of the cer-
ebellum and the dentate fascia of the hippocampus, the 
pathologic grade was validated using averaged counts in 
40× and 20× magnification microscopic fields, respec-
tively. Slides were imaged using a Zeiss AxioImager Z1 
microscope (Carl Zeiss Microscopy).
electron microscopy (eM) and immuno-electron 
microscopy (immuno-eM)
To examine the filamentous structure of recombinant 
gST-(gA)50 proteins, recombinant gST or gST-(gA)50 
proteins were diluted to 1 µg/µl in 20 mM Tris–HCl, 
pH 7.5, 50 mM KCl, 10 mM MgCl2 in a final volume of 
30 µl. The samples were incubated at 30 °C for 6 h, and 
then diluted to 0.1 µg/µl by reaction buffer and loaded 
onto grids for regular eM analysis. For immuno-eM 
analysis, mouse monoclonal anti-gST antibody (1:20, 
Thermo Scientific) was used as primary antibody, and 
goat anti-mouse Igg conjugated with 6 nm colloidal 
gold particles (1:20, Jackson Immunoresearch labo-
ratories) was used as the secondary antibody. To exam-
ine the filamentous structure of poly(gA) proteins in 
c9FTD/AlS patients, small pieces (1.5 × 1.5 × 1 mm) 
of cerebellar folia or hippocampus from formalin-fixed 
brains were dissected and processed for routine electron 
microscopy (eM) or post-embedding immunogold eM 
as previously described [34]. rabbit polyclonal anti-
poly(gA) antibody (1:50) was used as a primary anti-
body and goat anti-rabbit Igg conjugated with 18 nm 
colloidal gold particles (1:20, Jackson Immunoresearch 
laboratories) was used as the secondary antibody. Thin 
sections stained with uranyl acetate and lead citrate were 
examined with a Philips 208S electron microscope (FeI) 
fitted with a gatan 831 Orius CCD camera (gatan). Dig-
ital images were processed with Adobe Photoshop CS5 
software.
Preparation of urea fractions and dot blot analysis of frozen 
cerebellar tissue
The urea fraction of human tissues was prepared as previ-
ously described [46, 75]. In brief, ~100 mg frozen post-
mortem cerebellar tissue from carriers and non-carriers 
of the C9ORF72 repeat expansion was subjected to a 
sequential extraction protocol using low-salt buffer, high 
salt–Triton X-100 buffer, myelin floatation buffer, and 
sarkosyl buffer. Sarkosyl-insoluble material was finally 
extracted in urea buffer and saved as the urea fraction. 
For dot blots, urea fractions (2 µl per sample) were dotted 
directly onto nitrocellulose membrane. After incubation at 
37 °C for 30 min, the membrane was blocked with 5 % 
nonfat dry milk in Tris-buffered saline containing 0.1 % 
Triton X-100 (TBST) for 1 h, then incubated with rabbit 
polyclonal anti-poly(gA) antibody (1:1000) overnight at 
4 °C. The membrane was washed in TBST, and then incu-
bated with donkey anti-rabbit Igg conjugated to horserad-
ish peroxidase (1:5000, Jackson Immunoresearch labo-
ratories) for 1 h. Protein expression was visualized by 
enhanced chemiluminescence treatment and exposure to 
a film.
Table 2  Poly(gA) 
neuropathology in c9FTD/AlS 
cases
± Sparse, + mild, ++ 
moderate, +++ severe, ** cells 
autolyzed, CA3/2 hippocampus 
proper, DF dentate fascia, GCL 
granule cell layer, ML molecular 
layer, Path Dx neuropathologic 
diagnosis
Path Dx Case # Hippocampus Temporal cortex Frontal cortex Thalamus Cerebellum
DF CA3/2 Ml gCl
FTlD 1 ++ ++ ++ ++ ++ ++ +++
FTlD 2 + + ++ ++ ± + ++
FTlD 3 + + + + ++ ++ +
FTlD 4 ++ ++ ++ + ++ + +++
FTlD–MND 5 ++ ++ +++ +++ + ++ +++
FTlD–MND 6 + + + ++ ++ ± ++
AlS 7 ++ + ++ ++ ++ + **
AlS 8 +++ + ++ ++ + ++ +++
AlS 9 ++ ++ ++ ++ ± ++ +++
AlS 10 ++ ++ ++ ++ + ++ ++
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Preparation of cell lysates
HeK293T cells grown in 6-well plates were transfected 
for 48 h with 1 µg of an expression vector [gFP or gFP-
(gA)50] or 5 µg of an expression vector [ATg-(gA)50-V5, 
ATg-(gA)100-V5, ATg-(gA)50-3T or (gA)50-3T] using 
lipofectamine 2000 (life Technologies). To prepare Tri-
ton X-100 soluble and insoluble fractions, cell pellets 
expressing gFP or gFP-(gA)50 were lysed in Co-IP buffer 
(50 mM Tris–HCl, pH 7.4, 300 mM NaCl, 1 % Triton 
X-100, 5 mM eDTA) containing PMSF as well as pro-
tease and phosphatase inhibitors. lysates were sonicated 
on ice, and then centrifuged at 16,000g for 20 min. Super-
natants were saved as Triton X-100-soluble fractions. The 
insoluble pellets were dissolved in Co-IP buffer plus 2 % 
SDS, PMSF, and both a protease and phosphatase inhibi-
tor mixture. After sonication, lysates were centrifuged at 
16,000g for 20 min, and these supernatants were saved 
as Triton X-100-insoluble fractions. To prepare total cell 
lysates, pellets from cells transfected with ATg-(gA)50-
V5, ATg-(gA)100-V5, ATg-(gA)50-3T or (gA)50-3T con-
structs were lysed in Co-IP buffer plus 2 % SDS, PMSF, 
and both protease and phosphatase inhibitor mixture. After 
sonication, lysates were centrifuged at 16,000g for 20 min. 
The protein concentration of supernatants was determined 
by BCA assay (Thermo Scientific) prior to Western blot 
analysis.
Fluorescence in situ hybridization (FISH)
To examine rNA foci, cells were subjected to FISH. 
In brief, HeK293T cells grown on glass coverslips in 
24-well plates were transfected with 0.5 µg gFP-(gA)50 
or gFP-c9(gA)50 expression vectors made, respectively, 
with a synthetic sequence [(ggXgCX)50; gFP-(gA)50] or 
a pathological sequence [(ggggCC)50; gFP-c9(gA)50]. 
After 24 h, cells were fixed in 4 % paraformaldehyde for 
20 min, permeabilized in DePC-treated PBS-0.2 % Triton 
X-100 for 10 min, and washed 3 times with DePC-treated 
PBS. Cells were hybridized with denatured Cy3-conju-
gated probe (5′-Cy3/ggCUCCAgCACCAgCACCUgC
gCC-3′, 2 ng/µl) for the synthetic sequence, or (5′-Cy3
/ggCCCCggCCCCggCCCCggCCCC-3′, 2 ng/µl) for 
the pathological sequence, overnight at 37 °C. The com-
position of the hybridization buffer was 50 % formamide, 
10 % dextran sulfate, 0.1 mg/ml yeast trNA, 2 × SSC, 
50 mM sodium phosphate. Cells were then washed once 
with 50 % formamide/1 × SSC for 30 min at 37°C, and 
twice with DePC-PBS at room temperature for 5 min. 
Then, the cells were counterstained with Hoechst 33258 
(1 µg/ml, life Technologies). Immunostained cells 
were visualized using a Zeiss lSM 510 MeTA confocal 
microscope.
Cell culture, immunofluorescence staining 
and quantification of activated caspase-3-positive cells
HeK293T cells grown on glass coverslips in 24-well plates 
were transfected with 0.5 µg of an expression vector [gFP, 
gFP-(gA)5, gFP-(gA)50, ATg-(gA)50-V5, ATg-(gA)100-
V5, ATg-(gA)50-3T or (gA)50-3T] using lipofectamine 
2000 (life Technologies). After 48 h, media was collected 
for analysis using an lDH assay (Promega) to assess cell 
toxicity. In addition, cells were fixed with 4 % paraform-
aldehyde in PBS for 15 min, and then permeabilized with 
PBS–0.5 % Triton X-100 for 10 min. To examine caspase-3 
activation, cells were blocked with 5 % nonfat milk for 1 h 
at room temperature, then incubated overnight at 4 °C with 
rabbit polyclonal anti-activated caspase-3 antibody (9661, 
1:250, Cell signaling) and mouse monoclonal anti-HA anti-
body (clone 3F10, 1:1000, roche; used for cells express-
ing HA-tagged proteins) or mouse monoclonal anti-V5 
antibody (r960-25, 1:2000, life Technologies; used for 
cells expressing V5-tagged proteins). To determine whether 
poly(gA) inclusions are ubiquitin- and p62-positive, cells 
expressing ATg-(gA)100-V5 were incubated with rab-
bit polyclonal anti-V5 antibody (V8137, 1:2000, Sigma) 
and mouse monoclonal anti-ubiquitin (clone Ubi-1, 1:100, 
eMD Millipore) or mouse monoclonal anti-p62 (610833, 
1:100, BD Biosciences) antibodies. To examine the er-
golgi distribution of gFP-(gA)50 inclusions, cells were 
subjected to immunofluorescence staining using rabbit 
polyclonal anti-giantin antibody (ab24586, 1:250, Abcam) 
or mouse monoclonal anti-KDel antibody (10C3, 1:500, 
Stressgen). After washing, cells were incubated with the 
corresponding Alexa Fluor 488 donkey anti-mouse and 
Alexa 568-conjugated donkey anti-rabbit secondary anti-
body (1:500, Molecular Probes) at room temperature 
for 2 h. Hoechst 33258 (1 µg/ml, life Technologies) was 
used to stain cellular nuclei. Images were obtained on a 
Zeiss lSM 510 MeTA confocal microscope. To quantify 
the number of cells positive for activated caspase-3 stain-
ing, coverslips mounted on slides were scanned by Aperio 
ScanScope. Sixteen fields were randomly selected under 
20× magnification. For each field, the number of activated 
caspase-3-positive cells and the number of gFP-positive 
cells were counted in a blinded fashion using MetaMorph 
software. These counts were used to calculate the average 
percentage of activated caspase-3-positive cells in cells 
expressing gFP, gFP-(gA)5 or gFP-(gA)50.
Primary neuronal culture preparation, quantification 
of neurite outgrowth and immunofluorescence staining
Primary neuronal cultures were prepared as previously 
described [76]. In brief, the cortex from embryonic day 
18 (e18) mice was dissected and digested. Following 
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centrifugation to collect the cell pellet, cells were resus-
pended in Neurobasal A (life Technologies) supplemented 
with B27, gMAX, gentamicin and bFgF (life Technolo-
gies). Neurons were seeded at a density of 9 × 103 cells/
well in 96-well plates, 2 × 104 cells/coverslip in 24-well 
plates, or 7 × 105 cells/well in 6-well plates. At day in vitro 
4, neurons were transduced to express gFP, gFP-(gA)50, 
or ATg-(gA)100-V5. The following numbers of rAAV1 
genome particles were used for 96-, 24- and 6-well plates, 
respectively: 1 × 109, 1.2 × 109, and 1 × 1010. Quantifi-
cation of neurite outgrowth was performed as previously 
described [19, 76], using neurons in 96-well plates immu-
nostained 5 days post-transduction with mouse monoclonal 
anti-MAP2 antibody (M9942, 1:1000, Sigma) and rab-
bit polyclonal anti-V5 antibody (V8137, 1:2000, Sigma) 
(used for cells expressing V5-tagged proteins). The aver-
age total neurite length per neuron was calculated for all 
groups using counts obtained in a blinded fashion. Cas-
pase-3 activation was evaluated using neurons on glass 
coverslips in 24-well plates. Seven days post-transduction, 
neurons were fixed and immunostained using a rabbit poly-
clonal anti-activated caspase-3 antibody (9661, 1:250, Cell 
signaling) and/or mouse monoclonal anti-V5 antibody 
(r960-25, 1:2000, life Technologies). Western blot analy-
sis and lDH studies were conducted using neurons grown 
in 6-well plates. Seven days post-transduction, media 
was collected for the lDH assay, and cells were lysed in 
Co-IP buffer with 2 % SDS, PMSF, as well as protease and 
phosphatase inhibitors. lysates were sonicated and centri-
fuged at 16,000g for 20 min. Supernatants were saved and 
the protein concentration was determined by BCA assay. 
Samples were analyzed by Western blot. Some cultures 
were exposed to different treatments. Non-transduced neu-
rons were treated with tunicamycin (10 µg/µl, Sigma) or 
Mg-132 (10 µM, eMD4Biosciences) at day in vitro 6, then 
harvested the next day. Neurons expressing gFP-(gA)50 
were treated with a fresh preparation of TUDCA (0.25 or 
0.5 mM, eMD4Biosciences) 1 day after transduction or 
salubrinal (2.5 or 5.0 µM, Sigma) 3 days after transduc-
tion. Seven days after transduction, TUDCA- or salubrinal-
treated neurons were harvested for analysis.
Proteasome activity assay
Proteasome activity assays were performed as previously 
described [61]. In brief, pellets of neurons subjected to 
different treatments were lysed in 350 μl of assay buffer 
(10 mM Tris–HCl, 0.5 mM DDT, 5 mM ATP, 0.035 % 
SDS, 5 mM MgCl2, pH 7.8). After homogenization, cell 
lysates were centrifuged at 1,000g for 10 min. The super-
natants were collected and the protein concentration was 
determined by Bradford assay (Thermo Scientific). Then, 
the proteasome substrate Suc-leu-leu-Val-Tyr-AMC was 
added to 300 μl of lysate at a final concentration of 40 μM. 
The reaction was started by incubating samples at 37°C 
for 30 min, and then terminated by adding 75 μl H2O and 
11.25 μl ethanol to quench the substrate. After centrifuga-
tion at 1,000g for 3 min, 100 μl of each sample was added 
into a black 96-well plate in triplicate. Fluorescence was 
measured at 360 nm excitation and 465 nm emission. Data 
was normalized to the gFP control group.
live cell imaging
HeK293T cells grown in 96-well plates were transfected 
with 0.1 µg of gFP-(gA)50 vector using lipofectamine 
2000 (life Technologies). To monitor inclusion formation 
12 h post-transduction, images of live cells were obtained 
every 5 min for 5 h using the BD pathway 855. The result-
ing images were combined to create the video shown in the 
Online resources section.
Western blot analysis
Western blot analysis was performed as previously 
described [75, 76]. In brief, samples were heated in lae-
mmli’s buffer, and equal amounts of protein were loaded 
into 10-well 10 % or 4–20 % Tris–glycine gels (Novex). 
After transfer, blots were blocked with 5 % nonfat dry milk 
in TBST for 1 h, then incubated with a rabbit polyclonal 
anti-gFP antibody (A-6455, 1:2000, life Technologies), 
rabbit polyclonal anti-activated caspase-3 antibody (9661, 
1:1000, Cell signaling), mouse monoclonal anti-V5 anti-
body (r960-25, 1:2000, life Technologies), rabbit poly-
clonal anti-poly(gA) serum (1:4000), mouse monoclonal 
anti-gST antibody (MA4-004, 1:2000, Thermo Scientific), 
mouse monoclonal anti-HA antibody (clone 3F10, 1:1000, 
roche), mouse monoclonal anti-Myc antibody (clone 
9e10, 1:1000, roche), mouse monoclonal anti-Flag anti-
body (F3165, 1:1000, Sigma), rabbit polyclonal anti-ubiq-
uitin antibody (Z0458, 1:1000, Dako), mouse monoclonal 
anti-BIP antibody (610978, 1:1000, BD Biosciences), rab-
bit polyclonal anti-CHOP antibody (sc-575, 1:200, Santa 
Cruz Biotechnology), rabbit polyclonal anti-phospho-
PerK (sc-32577, 1:500, Santa Cruz Biotechnology), rab-
bit polyclonal anti-PerK (sc-13073, 1:1000, Santa Cruz 
Biotechnology), rabbit polyclonal anti-ATF6 (sc-22799, 
1:1000, Santa Cruz Biotechnology), rabbit polyclonal anti-
phospho-eIF2α (9721, 1:500, Cell signaling) or mouse 
monoclonal gAPDH antibody (H86504 M, 1:10000, 
Meridian life Science) overnight at 4°C. Membranes 
were washed in TBST and incubated with donkey anti-
rabbit or anti-mouse Igg conjugated to horseradish peroxi-
dase (1:5000; Jackson Immunoresearch) for 1 h. Protein 
expression was visualized by enhanced chemiluminescence 
treatment and exposure to film.
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rNA extraction, semi-quantitative PCr and quantitative 
PCr (qrT-PCr)
Total rNA was extracted from HeK293T cells, neurons 
or frozen postmortem frontal cortex tissues using the 
rNAeasy Plus Mini Kit (QIAgeN) as per the manufac-
turer’s instructions, combined with an in-column DNase 
I digestion step. rNA integrity was obtained using the 
Agilent 2100 Bioanalyzer (Agilent Technologies). cDNA 
was obtained after reverse-transcription polymerase 
chain reactions using 500–2000 ng of rNA with ran-
dom primers and the High Capacity cDNA Transcrip-
tion Kit (Applied Biosystems) as per the manufacturer’s 
instructions. To examine XBP1 splicing in neurons, 2 μl 
of cDNA was used in a 20 μl reaction according to the 
manufacturer’s protocol for a Taq PCr Core kit (Qiagen). 
The PCr primers for XBP1 and gAPDH were used as 
in previously described [28]. The amplification condi-
tions consisted of an initial denaturation step at 95 °C 
for 5 min; 10 cycles of 94 °C for 20 s, 65–55 °C touch-
down for 20 s, and 72 °C for 30 s; 35 cycles of 94 °C 
for 20 s, 58 °C for 20 s, and 72 °C for 30 s, and a final 
extension at 72 °C for 5 min. The PCr products were run 
on 2 % agarose gels for 35 min at 135 V. The intensity 
of unspliced and spliced XBP1 bands was quantified by 
densitometric analysis using Fujifilm Multigauge soft-
ware, and then the percentage of unspliced or spliced 
XBP1 was calculated.
To quantify mrNA levels of gFP, gFP-(gA)5 and gFP-
(gA)50 in HeK293T cells or neurons, quantitative PCr 
(qrT-PCr) was conducted in triplicate for all samples using 
SYBr green assay (life Technologies) on an ABI Prism 
7900HT Fast real-Time PCr System (Applied Biosys-
tems). The primers used were: gFP: 5′-gAAgCgCgAT-
CACATggT-3′ and 5′-CCATgCCgAgAgTgATCC-3′; 
gAPDH: 5′-CATggCCTTCCgTgTTCCTA-3′ and 
5′-CCTgCTTCACCACCTTCTTgAT-3′. The mrNA 
values of gFP, gFP-(gA)5 and gFP-(gA)50 were normal-
ized to gAPDH values, an endogenous transcript control. 
To quantify er stress markers in frontal cortex tissues from 
AlS patients with or without the C9ORF72 repeat expan-
sion (Table 3), qrT-PCr was performed using TaqMan 
assays (life Technologies) for ATF4 (Hs00909569_g1), 
CHOP (Hs00358796_g1), or BIP (Hs00946350_g1), or a 
SYBr green assay for rPlP0 (primers: 5′-TCTACAAC-
CCTgAAgTgCTTgAT-3′ and 5′-CAATCTgCAgA-
CAgACACTgg-3′). The mrNA values of ATF4, CHOP, 
and BIP were normalized to rPlP0 values, an endogenous 
transcript control. Since it has been reported that gAPDH 
expression is altered in neurodegenerative diseases [11], 
we evaluated several endogenous controls by qrT-PCr in 
the frontal cortex regions and rPlP0 was chosen because 
this transcript presented overall low Ct values and lowest Ct 
variation (unpublished data). In addition, rPlP0 has been 
used as a stable reference gene in previous studies [1, 16, 
31].
Table 3  AlS cases with or without the C9ORF72 repeat expansion used for qPCr analysis of er stress markers
Path Dx Case # (continued from Table 2) C9ORF72 repeat expansion gender Age of onset Age of death
c9AlS 7 Y M 52 58
c9AlS 9 Y F n/a 49
c9AlS 10 Y F n/a 41
c9AlS 11 Y F 61 64
c9AlS 12 Y M 56 58
c9AlS 13 Y M 49 53
c9AlS 14 Y F n/a 50
c9AlS 15 Y F n/a 50
AlS 16 N M 45 50
AlS 17 N M 53 58
AlS 18 N F n/a 53
AlS 19 N M n/a 47
AlS 20 N F n/a 60
AlS 21 N F n/a 65
AlS 22 N F n/a 69
AlS 23 N F n/a 70
AlS 24 N F n/a 72
AlS 25 N F n/a 79
AlS 26 N F n/a 80
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Results
Poly(gA) proteins form abundant inclusions 
in c9FTD/AlS
To investigate the contribution of poly(gA) inclusions 
to c9FTD/AlS pathogenesis, we generated a rabbit poly-
clonal antibody using recombinant gST-(gA)50 protein 
as the antigen. Analysis of recombinant gST-(gA)50, in 
comparison to gST alone, confirmed that it forms high 
molecular weight species (arrow, Online resource 1a) and 
filamentous structures in vitro (Online resource 1b and c), 
rendering it an ideal antigen for the production of antibod-
ies to detect poly(gA) pathology. Indeed, the resulting anti-
bodies, which specifically detect poly(gA) protein and no 
other c9rAN proteins (Online resource 1d), stain inclu-
sions throughout the CNS of c9FTD/AlS cases (Fig. 1a–f; 
Table 2) but not age-matched FTlD-TDP and AlS cases 
without the C9ORF72 repeat expansion (Online resource 
1e). Further confirming specificity of this novel polyclonal 
poly(gA) antibody, immunostaining c9FTD/AlS tissues 
with pre-immune serum was negative (Online resource 1f). 
The distribution of anti-poly(gA) immunoreactive inclu-
sions in c9FTD/AlS (Table 2) paralleled that of poly(gP) 
inclusions, which we previously reported to be enriched in 
the cerebellum, hippocampus, and neocortex [3]. Poly(gA) 
inclusions were predominantly neuronal cytoplasmic inclu-
sions (NCI), but neuronal intranuclear inclusions (NIIs) 
(arrow in insert, Fig. 1a) were also observed. electron 
microscopy (eM) studies of NCI in granule cells of the cer-
ebellum (Fig. 1g) showed that the inclusions contain 15–
17 nm filaments (arrow, Fig. 1h). Immuno-eM with anti-
poly(gA) antibody confirmed the localization of poly(gA) 
proteins to these filaments (arrow, Fig. 1i). Consistent with 
these findings, insoluble poly(gA) proteins were detected 
in urea fractions of c9FTD/AlS cerebellar tissue, but not 
in cerebellar tissue from FTlD and AlS cases with no 
expanded repeat, as assessed by dot blot (Fig. 1j). 
Poly(gA) proteins form inclusions and are toxic 
in cultured cells
In investigating the potential contribution of poly(gA) pro-
teins to neurodegeneration in c9FTD/AlS, we generated 
expression constructs for CMV-promoted, ATg-initiated 
translation of synthetic repeats encoding gFP-tagged (gA)5 
or (gA)50. For comparison purposes, we also produced vec-
tors for the expression of all other c9rAN proteins [gFP-
(gP)47, gFP-(gr)50, gFP-(Pr)50 or gFP-(PA)50]. Similar 
to the intracellular localization of gFP alone, gFP-(gP)47 
and gFP-(PA)50 were diffusely distributed throughout 
cells, whereas gFP-(gr)50 and gFP-(Pr)50 accumulated 
into discrete nuclear structures (Online resource 2). In 
contrast, gFP-(gA)50 formed many inclusions, the major-
ity of which were cytoplasmic, although the occasional 
nuclear inclusion was observed (arrow, Fig. 2a). These 
results suggest that, among c9rAN proteins, poly(gA) is 
especially aggregation prone. The propensity of poly(gA) 
proteins to aggregate, however, is dependent on repeat 
length given that gFP-(gA)5 remained diffusely distrib-
uted in transfected cells (Fig. 2a). Poly(gA) aggregation 
also appears to be a relatively rapid process. Upon monitor-
ing gFP-(gA)50 inclusion formation in living cells, it was 
observed that, within a span of only 5 min, diffuse gFP-
(gA)50 can quickly form a small aggregate, which then 
goes on to become a large inclusion within approximately 
30 min (Fig. 2b, Online resource 3). The aggregation of 
gFP-(gA)50 is not likely the result of a tag artifact since 
poly(gA) inclusions were also observed in cells expressing 
ATg-(gA)100-V5 (Fig. 2c). Of note, (gA)100-V5 inclusions 
were ubiquitin- and p62-positive (Fig. 2c), reminiscent of 
poly(gA) pathology in c9FTD/AlS [2, 44]. likewise, sim-
ilar to the filaments observed in c9FTD/AlS tissue, gFP-
(gA)50 inclusions in cultured cells were composed of fila-
mentous structures (arrow, Fig. 2d). Consistent with these 
findings, Western blot analysis of Triton X-100 soluble 
and insoluble transfected cell fractions revealed that, while 
gFP was detected as a monomer in the soluble fraction, 
gFP-(gA)50 accumulated in both soluble and insoluble 
fractions as high molecular weight species (Fig. 2e), akin 
to the high molecular weight bands of recombinant gST-
(gA)50 noted above. Such high molecular weight species 
were also detected in lysates from cells expressing ATg-
(gA)50-HA, ATg-(gA)50-V5 or ATg-(gA)100-V5, again 
ruling-out the possibility that formation of high molecular 
weight poly(gA) proteins is driven by the tag to which it is 
fused (Online resource 4b and d).
The purpose of generating a vector that encodes a syn-
thetic repeat sequence for the expression of gFP-(gA)50, 
specifically one in which a random nucleotide was intro-
duced in the 3rd and 6th codon positions (ggXgCX), 
was to enable the evaluation of poly(gA) protein toxicity 
without the confounding contribution of rNA foci or other 
c9rAN proteins, the production of which may depend on 
the secondary structure of g4C2 repeat-containing rNA 
[23, 57, 64, 77]. To confirm that the rNA encoded by the 
synthetic sequence does not result in foci formation, rNA-
FISH of gFP-(gA)50-expressing cells was undertaken. As 
above, poly(gA) inclusions were observed in cells express-
ing gFP-(gA)50, but no rNA foci were detected (Fig. 2f). 
Conversely, both foci and poly(gA) inclusions were 
found in cells expressing gFP-c9(gA)50, which encodes 
50 unadulterated g4C2 repeats (Fig. 2f). Next, to confirm 
that our synthetic (gA)50 sequence does not undergo rAN 
translation, we generated expression vectors containing 
the (gA)50 sequence with or without an ATg start codon. 
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The vectors include six stop codons upstream of (±)ATg-
(gA)50 (two in each reading frame) to prevent ATg-initi-
ated translation from the vector sequence, and a different 
tag in each reading frame downstream of (±)ATg-(gA)50 
to monitor protein expression in all frames [i.e., frame 1: 
(gA)50-HA; frame 2: novel rAN protein-Myc; frame 3: 
novel rAN protein-Flag] (Online resource 4a). Western 
blot analysis revealed that cells transfected with the ATg-
(gA)50-3T expression vector produce (gA)50-HA proteins 
but not Myc- or Flag-tagged proteins rAN translated from 
Fig. 1  Neuropathology of c9rAN poly(gA) proteins in C9ORF72 
repeat expansion cases. a–f Immunohistochemical analysis shows 
that poly(gA) proteins accumulate throughout the central nervous 
system of C9ORF72 repeat expansion carriers as neuronal cytoplas-
mic inclusions and neuronal intranuclear inclusions (arrow in insert, 
a). regions with a particularly high burden include the dentate fascia 
of the hippocampus (a; Case 8), the hippocampus proper (b; CA3/2; 
Case 10), the anterior thalamus (c; Case 4), the frontal cortex (d; lay-
ers IV–V; Case 7), the cerebellar molecular layer (e; Case 1) and the 
cerebellar internal granule cell layer (f; Case 9). Scale bar represents 
25 µm (a–e) and 20 µm (f). regular electron microscopy (eM) of 
granule cells of the cerebellar cortex from a c9FTD-MND case shows 
that cytoplasmic inclusions (g) are composed of 15–17 nm filaments 
(arrow, h). Immuno-eM with anti-poly(gA) antibody labeled with 
gold particles (18 nm) reveals poly(gA) proteins localize to filaments 
(arrow, i). Scale bars represent 0.5 μm (g), 100 nm (h), and 50 nm 
(i). j Dot blot reveals that anti-poly(gA) immunoreactivity in cerebel-
lar urea fractions is specific to c9FTD/AlS. each dot represents one 
case
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Fig. 2  Poly(gA) proteins form inclusions and are toxic in cul-
tured cells. a expression of gFP-(gA)50 in cultured HeK293T cells 
results in the formation of cytoplasmic or nuclear (arrow) inclusions. 
Scale bar represents 5 µm. b representative images of live cells 
demonstrating how quickly inclusions form (compare the image at 
100 min to the image at 105 min). c Poly(gA) inclusions are ubiq-
uitin and p62-positive in cultured cells. Scale bar represents 5 µm. 
d Immuno-electron microscopy with an anti-gFP antibody labeled 
with gold particles shows that cytoplasmic gFP-(gA)50 inclusions 
are composed of filamentous structures (arrow). Scale bar repre-
sents 100 nm. e Western blot analysis of Triton X-100 soluble (S) and 
insoluble (Ins) cell lysates shows that a portion of poly(gA) proteins 
forms high molecular weight material. f Cultured cells were made 
to express gFP-(gA)50, which encodes a synthetic repeat sequence 
(ggXgCX)50 (where X represents a random nucleotide), or gFP-
c9(gA)50, in which the pathological repeat sequence (ggggCC)50 
was used. Post-transfection, cells were subjected to rNA fluores-
cence in situ hybridization (FISH) to visualize rNA foci. gFP-
(gA)50 expression leads to the formation of poly(gA) inclusions, 
but transcripts from this sequence do not form rNA foci. In contrast, 
both rNA foci and poly(gA) inclusions are formed in cells that 
express gFP-c9(gA)50. Scale bar represents 5 µm. g Quantitative 
analysis and representative image showing that cells bearing inclu-
sions of gFP-(gA)50 are immunoreactive for activated caspase-3, 
a crucial mediator of cell death. Scale bar represents 5 µm. h lDH 
activity in media, an indicator of cell toxicity, is increased in cells 
expressing gFP-(gA)50. i Transgene mrNA levels are comparable 
among cells expressing gFP, gFP-(gA)5 and gFP-(gA)50. Data rep-
resent the mean ± SeM from sixteen random selected fields (g) or 
three separate experiments (h and i). ***P < 0.001, as analyzed by 
one-way analysis of variance followed by Tukey’s post hoc analysis
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reading frames 2 or 3 (Online resource 4b). Moreover, 
no proteins were expressed from any of the three reading 
frames in cells transfected with the ATg-free (gA)50-3T 
vector (Online resource 4b), despite comparable transgene 
mrNA levels in ATg-(gA)50-3T and (gA)50-3T expressing 
cells (Online resource 4c). Together, our results indicate 
that our synthetic (gA)50 sequence is not rAN translated 
and results only in the production of poly(gA) proteins.
Having excluded the potential involvement of foci for-
mation and rAN translation in our poly(gA)-expressing 
cellular model, we next evaluated whether poly(gA) 
expression and aggregation are associated with cellular tox-
icity using caspase-3 activation as an indicator of cell death. 
Compared to the 0.6 % of gFP- or gFP-(gA)5-expressing 
cells that showed signs of activated caspase-3, the percent-
age of cells positive for activated caspase-3 was approxi-
mately eightfold higher upon expression of gFP-(gA)50 
(Fig. 2g, Online resource 4e). Increased activation of cas-
pase-3 was similarly observed in cells bearing inclusions of 
(gA)50-V5, (gA)100-V5 or (gA)50-HA (Online resource 
4f). Poly(gA)-induced cytotoxicity was further confirmed 
by increased lDH levels in culture media of gFP-(gA)50-
expressing cells compared to lDH levels in media from 
cells expressing either gFP alone or gFP-(gA)5 (Fig. 2h), 
despite comparable levels of transgene mrNA (Fig. 2i).
expression of poly(gA) proteins causes er stress 
and neuronal death
Since gFP-(gA)50 expression in immortalized cultured 
cells caused a modest, but statistically significant, increase 
in caspase activation, we next sought to determine whether 
expression of poly(gA) proteins in primary neurons would 
result in inclusion formation and a similar or greater degree 
of toxicity. To this end, we generated adeno-associated 
viral vectors (AAV1) for the expression of gFP or gFP-
(gA)50 for transduction of primary mouse cortical neurons 
at day in vitro 4. Seven days later, increased lDH levels 
were observed in medium from neurons expressing gFP-
(gA)50 but not gFP (Fig. 3a), despite comparable levels 
of transgene mrNA (Fig. 3b). Additional signs of toxicity 
observed specifically in gFP-(gA)50-expressing neurons 
included caspase-3 activation in cells harboring inclusions 
(Fig. 3c–e) and stunted neurite outgrowth (Online resource 
5a and b). Impaired neurite outgrowth was also observed 
in primary neurons expressing ATg-(gA)100-V5 (Online 
resource 5a and b), the expression of which resulted in the 
formation of poly(gA) inclusions positive for ubiquitin and 
p62 (Online resource 5c). 
Similarly to our findings above, immuno-eM studies 
showed that poly(gA) inclusions in gFP-(gA)50-express-
ing neurons were composed of filaments (arrow, Online 
resource 5d), and that the expression of gFP-(gA)50, but 
not gFP alone, resulted in the formation of high molecular 
weight species (Fig. 3d). gFP-(gA)50 expression was also 
associated with the accumulation of ubiquitinated proteins 
(Fig. 3d), suggesting that poly(gA) proteins impair the 
activity of the ubiquitin–proteasome system (UPS). Indeed, 
proteasome activity was found to be significantly decreased 
in neurons expressing gFP-(gA)50 compared to those 
expressing gFP (Fig. 3f).
Since it is well established that proteasome inhibition 
causes er stress [17, 32, 47, 50, 53], our findings may 
indicate that expression of poly(gA) proteins leads to er 
stress. Although poly(gA) inclusions did not localize to the 
er-golgi secretory compartment (Online resource 5e), 
poly(gA) expression nonetheless increased levels of bind-
ing immunoglobulin protein (BIP), an er chaperone pro-
tein, phosphorylated protein kinase rNA (PKr)-like er 
kinase (PerK), a critical transducer of er stress, and tran-
scriptional factor C/eBP homologous protein (CHOP), a 
downstream target of PerK (Fig. 3d, e), indicative of acti-
vation of the PerK–CHOP er stress-associated signaling 
pathway. However, poly(gA) expression did not influence 
other pathways normally triggered by er stress; neither 
induction of the activating transcription factor 6 (ATF6) 
axis, assessed by ATF6 cleavage (Fig 3d, e), nor of the ino-
sitol-requiring protein-1 (Ire1) axis, assessed by abnormal 
X-box-binding protein 1 (XBP1) splicing (Fig. 3g, h), were 
observed in neurons expressing gFP-(gA)50. As a positive 
control, non-transduced neurons were treated with tunica-
mycin, an er stress inducer. This resulted in increased lev-
els of BIP, PerK and CHOP (Online resource 5f and g), 
as well as abnormal splicing of XBP1 (Fig. 3g, h), but not 
ATF6 cleavage (Online resource 5f and g), suggesting that 
the ATF6 pathway is less likely to be activated upon er 
stress in primary neurons. Of interest, tunicamycin treat-
ment resulted in the accumulation of ubiquitinated proteins 
(Online resource 5g) without direct inhibition of protea-
some activity (Fig. 3f), suggesting increased ubiquitination 
of misfolded proteins in the er.
like gFP-(gA)50 expression, expression of ATg-
(gA)100-V5 or exposure of neurons to the proteasome 
inhibitor, Mg-132, resulted in the accumulation of ubiqui-
tinated proteins, impairment of proteasome activity, as well 
as activation of caspase-3 and the PerK–CHOP pathway 
(Fig. 3f, Online resource 5f and g). These findings pro-
vide further support that poly(gA) expression in primary 
neurons inhibits proteasome activity and leads to er stress. 
We thus evaluated whether signs of heightened er stress 
are observed in C9ORF72 repeat expansion carriers. given 
that TDP-43 pathology has been associated with er stress 
[68, 70], and that both c9rAN protein pathology and TDP-
43 pathology are present in c9AlS, we compared c9AlS 
cases to sporadic AlS cases with TDP-43 pathology to 
exclude the potentially confounding effect of TDP-43 on 
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er stress. We also chose to examine activating transcription 
factor 4 (ATF4) and CHOP, two er stress markers involved 
in the PerK–CHOP pathway, given that poly(gA) protein 
expression in primary neurons specifically activates this 
pathway. Of importance, quantitative PCr analysis revealed 
that mrNA levels of ATF4 and CHOP were significantly 
increased in frontal cortex of c9AlS cases (Fig. 3i). BIP 
levels, however, did not differ (Fig. 3i).
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er stress inhibitors, salubrinal and TUDCA, 
provide rescue against poly(gA)-induced er stress 
and neurotoxicity
Since cell death associated with the PerK–CHOP sign-
aling pathway is partially mediated through the dephos-
phorylation of eukaryotic translation initiation factor 2α 
(eIF2α), which is regulated by the association of growth 
arrest and DNA damage inducible 34 (gADD34) with pro-
tein phosphatase 1 (PP1C) [24, 25, 42, 49], we examined 
the phosphorylation status of eIF2α in neurons expressing 
gFP-(gA)50. Western blot analysis revealed that, compared 
to gFP expression, expression of gFP-(gA)50 significantly 
reduced eIF2α phosphorylation (Figs. 3d, e, 4b, c). We thus 
evaluated the neuroprotective effects of salubrinal, a selec-
tive inhibitor of the gADD34–PP1C complex known to 
offer protection from er stress-associated cell death [9, 36, 
60], in neurons expressing gFP-(gA)50. Compared to vehi-
cle-treated gFP-(gA)50-expressing neurons, lDH activ-
ity in media (Fig. 4a) and caspase-3 activation (Fig. 4b, c) 
were significantly decreased in neurons treated with salu-
brinal (2.5 and 5 µM). This was accompanied by a dra-
matic increase in eIF2α phosphorylation (Fig. 4b, c), indi-
cating that salubrinal efficiently inhibits the activity of the 
gADD34–PP1C complex. Moreover, salubrinal at 5 µM 
decreased levels of BIP and phospho-PerK (Fig. 4b, c), 
although neither levels of gFP-(gA)50 mrNA and protein, 
ubiquitinated proteins, nor CHOP were altered (Fig. 4b–e). 
To further evaluate the role of er stress in poly(gA)-
induced toxicity, neurons expressing gFP-(gA)50 were 
treated with the chemical chaperone TUDCA, an inhibitor 
of er stress and associated toxicity [13, 38, 52, 72]. Com-
pared to vehicle-treated neurons expressing gFP-(gA)50, 
those treated with TUDCA (0.25 and 0.5 mM) showed a 
significant decrease in lDH activity in media (Fig. 5a) 
and caspase-3 activation (Fig. 5b, c). In addition, a dra-
matic decrease in phospho-PerK and CHOP levels were 
observed (Fig. 5b, c). Conversely, levels of gFP-(gA)50 
mrNA and protein, ubiquitinated proteins, and BIP were 
not altered by TUDCA treatment (Fig. 5b–e). Taken 
together, these findings indicate that inhibitors of er stress 
provide protection against poly(gA) neurotoxicity.
Discussion
rAN translation is becoming a well-established phenom-
enon in many repeat expansion disorders [3, 44, 65, 77]. 
Inclusions composed of rAN-translated proteins are now 
considered a neuropathological hallmark of c9FTD/AlS 
[3, 20, 43, 44, 78], but the contribution of this unconven-
tional form of translation to disease pathogenesis has so far 
been enigmatic. While each c9rAN protein may influence 
neuronal health differently, herein we provide evidence that 
poly(gA) proteins are neurotoxic and could thus be impli-
cated in the neurodegenerative processes of c9FTD/AlS.
Using cultured cells as a model to express c9rAN 
proteins of 50 repeating dipeptides, we observed that 
poly(gA) proteins formed ubiquitin- and p62-positive 
cytoplasmic inclusions, recapitulating the poly(gA) pathol-
ogy of c9FTD/AlS [2, 44]. In contrast, gFP-(PA)50 and 
gFP-(gP)47 remained diffusely distributed, whereas gFP-
(gr)50 and gFP-(Pr)50 aggregated in the nucleus, per-
haps as a result of repeat length and the fact that arginine 
(r)-rich regions can function as a nuclear localization sig-
nal. Because most poly(gr) and poly(Pr) inclusions in 
c9FTD/AlS patients are cytoplasmic [20, 43, 44, 78], the 
exclusively nuclear localization of gFP-(gr)50 and gFP-
(Pr)50 inclusions in cultured cells does not accurately 
reflect c9FTD/AlS neuropathology. These studies indicate 
that poly(gA) proteins are highly aggregation-prone com-
pared to the other c9rAN proteins, and that, depending on 
the model, longer repeat lengths should be used to evaluate 
poly(gP), poly(gr), poly(PA), and poly(Pr) aggregation 
and toxicity to better mimic c9FTD/AlS.
To study the neuropathologic profile of poly(gA) inclu-
sions in c9FTD/AlS, we generated a novel anti-poly(gA) 
antibody using as the antigen-purified recombinant gST-
(gA)50, which formed high molecular weight material and 
filaments in vitro. Consistent with previous reports [40, 44, 
56], we found that poly(gA) proteins were highly insoluble 
Fig. 3  expression of poly(gA) proteins in primary neurons causes 
neurotoxicity accompanied by UPS impairment and er stress. a 
expression of gFP-(gA)50, but not gFP, causes toxicity, as assessed 
by measuring lDH activity in media. b Transgene mrNA levels are 
comparable in neurons expressing gFP and gFP-(gA)50. c Activated 
caspase-3 is observed in MAP2-positive neurons bearing gFP-(gA)50 
inclusions. Scale bar represents 10 μm. Western blot (d) and densi-
tometric analysis of blots (e) show that expression of gFP-(gA)50 
in primary neurons leads to increased levels of activated caspase-3 
and ubiquitinated proteins. In addition, levels of the er stress mark-
ers, BIP, phospho-PerK and CHOP, are increased by gFP-(gA)50 
expression, whereas levels of phospho-eIF2α are decreased and ATF6 
levels remain unchanged. FL, Fg bands corresponding to full-length 
and fragmented ATF6, respectively. NS non-specific bands. f Pro-
teasome activity assays reveal that expression of poly(gA) proteins 
inhibit proteasome activity. Decreased proteasome activity is also 
observed in neurons treated with the proteasome inhibitor Mg-132, 
but not with the er stress inducer, tunicamycin. rT-PCr (g) and 
quantitative analysis (h) show that tunicamycin induces abnormal 
splicing of XBP1. However, expression of poly(gA) proteins or treat-
ment with Mg-132 does not result in this alteration. i mrNA levels 
of er stress markers, ATF4 and CHOP, are significantly increased 
in frontal cortex of AlS patients with the C9ORF72 repeat expan-
sion. N = 8 for c9AlS and N = 11 for sporadic AlS without the 
C9ORF72 repeat expansion. Data represents mean ± SeM of three 
separate experiments (a, b, e, f, h). ##P < 0.01, ###P < 0.001 and 
####P < 0.0001, as analyzed by unpaired t test. ***P < 0.001, as ana-
lyzed by one-way analysis of variance followed by Tukey’s post hoc 
analysis
◂
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in c9FTD/AlS brain tissue, and that anti-poly(gA) immu-
noreactive inclusions were abundant throughout the CNS. 
To our knowledge, we are the first to report that poly(gA) 
proteins form filamentous structures in c9FTD/AlS brain 
tissue. Similar filamentous structures were produced in 
experimental models; we show that poly(gA) proteins 
with as little as 50 dipeptide-repeats self-assembled and 
formed filaments in vitro, as well as in cultured cells and 
primary neurons. It was with some surprise that we found, 
using fluorescent microscopy of live cells, that poly(gA) 
proteins quickly (within mere minutes) converted from a 
diffuse distribution to compact, small aggregates. Perhaps 
this rapid transformation occurs when the concentration of 
poly(gA) proteins within a localized area meets a critical 
Fig. 4  Salubrinal, a selective 
inhibitor of eIF2α dephos-
phorylation, protects neurons 
against poly(gA)-induced er 
stress and toxicity. a Salubrinal, 
a small molecule known to pro-
vide rescue from er stress and 
associated cell death by inhibit-
ing the dephosphorylation of 
eIF2α, significantly decreases 
lDH activity in media of 
neurons expressing gFP-
(gA)50. Western blot (b) and 
densitometric analysis of blots 
(c) show that treatment of gFP-
(gA)50-expressing neurons with 
salubrinal significantly inhibits 
caspase-3 activation, increases 
eIF2α phosphorylation, and 
decreases levels of er stress 
markers, BIP and phospho-
PerK. Note that salubrinal 
treatment does not decrease 
levels of ubiquitinated proteins 
or CHOP. levels of gFP-
(gA)50 protein and mrNA are 
also not changed after salubrinal 
treatment, as shown by Western 
blot (b), densitometric analysis 
of blot (d), and qrT-PCr (e). 
NS indicates non-specific bands. 
Data represents mean ± SeM 
from three separate experi-
ments. *P < 0.05, **P < 0.01 
and ***P < 0.001, as analyzed 
by one-way analysis of variance 
followed by Tukey’s post hoc 
analysis
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Fig. 5  The chemical chaper-
one TUDCA protects neurons 
against poly(gA)-induced er 
stress and toxicity. a TUDCA, 
a chemical chaperone known to 
inhibit er stress and associated 
downstream pathways, signifi-
cantly decreases lDH activity 
in media of neurons expressing 
gFP-(gA)50. b, c Treatment 
of gFP-(gA)50-expressing 
neurons with TUDCA also 
significantly inhibits caspase-3 
activation, and decreases levels 
of er stress markers, phospho-
PerK and CHOP, as shown by 
Western blot (b) and densi-
tometric analysis of blots (c). 
Note that TUDCA treatment 
does not decrease levels of 
ubiquitinated proteins and BIP 
(b, c). Protein and mrNA levels 
of gFP-(gA)50 are not changed 
after TUDCA treatment (d, e). 
NS non-specific bands. Data 
represents mean ± SeM from 
three separate experiments. 
*P < 0.05, **P < 0.01 and 
***P < 0.001, as analyzed by 
one-way analysis of variance 
followed by Tukey’s post hoc 
analysis
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threshold. These small aggregates may then serve to seed 
the aggregation of soluble poly(gA) proteins, thus causing 
larger inclusions to form. Poly(gA) may similarly seed the 
aggregation of other proteins, including c9rAN proteins, 
given that poly(gA) proteins have been shown to co-local-
ize with various c9rAN proteins in neuronal inclusions in 
c9FTD/AlS [43, 44]. like poly(gA) proteins, polyA pro-
teins form high molecular weight species and inclusions in 
spinocerebellar ataxia type 8 (SCA8) [77], further indicat-
ing that proteins with long stretches of hydrophobic resi-
dues are especially aggregation-prone.
Cultured cell and primary neuron models provide evi-
dence that expression and aggregation of poly(gA) pro-
teins cause cellular toxicity. Compared to cells express-
ing gFP-(gA)5, which remained diffusely localized, 
there was enhanced cytotoxicity in cells expressing gFP-
(gA)50, which formed cytoplasmic inclusions. The major-
ity of gFP-(gA)50-expressing cells immunopositive for 
active caspase-3 contained such inclusions, suggesting 
that poly(gA) aggregation drives cell death. Nonetheless, 
it remains possible that soluble and insoluble poly(gA) 
oligomers also play a toxic role, as is speculated to be the 
case of inclusion-forming proteins, such as tau and TDP-
43, in other neurodegenerative diseases. Whatever the neu-
rotoxic poly(gA) species may be, our studies demonstrate 
that this c9rAN protein impairs function of the UPS in pri-
mary neurons. Compared to neurons expressing gFP alone, 
proteasome activity was significantly decreased in neurons 
expressing gFP-(gA)50, and this was accompanied with 
a dramatic accumulation of ubiquitinated proteins. These 
findings are consistent with reports demonstrating that pro-
tein aggregates and/or oligomers can impair the UPS [6, 7, 
30, 35, 71].
er-associated protein degradation (erAD), which con-
trols protein homeostasis in the er, is dependent on proper 
UPS activity [10, 12]; consequently, inhibition of the UPS 
impairs erAD, leading to the accumulation of misfolded 
proteins in the er and er stress [17, 32, 47, 50, 53, 74]. 
Under conditions of er stress, BIP, a master regulator of 
the unfolded protein response (UPr) that normally binds 
to and inhibits activity of er stress sensors, PerK, ATF6 
and Ire1, dissociates from these proteins. This disassocia-
tion leads to the activation of different downstream sign-
aling pathways such as PerK auto-phosphorylation, ATF6 
cleavage and XBP-1 splicing [25, 67]. Of note, the PerK–
CHOP pathway was selectively activated in primary neu-
rons expressing gFP-(gA)50, as evidenced by increased 
levels of the er sensor phospho-PerK, and its downstream 
target CHOP. Selective activation of the PerK–CHOP 
pathway was similarly observed in non-transduced neurons 
treated with the proteasome inhibitor, Mg-132. Other simi-
larities between gFP-(gA)50 expression and Mg-132-in-
duced proteasome inhibition include the accumulation of 
ubiquitinated proteins, decreased proteasome activity, and 
caspase-3 activation. In contrast, treatment of neurons with 
tunicamycin, an er stress inducer, activated both PerK–
CHOP and Ire–XBP1 pathways without impairing protea-
some activity. Together, our findings suggest that poly(gA) 
proteins indirectly induce er stress through proteasome 
inhibition. Of importance, we show that mrNA levels of 
er stress markers of the PerK–CHOP pathway, ATF4 and 
CHOP, are significantly increased in c9AlS cases com-
pared to sporadic AlS cases without the C9ORF72 repeat 
expansion. While no difference in BIP mrNA levels were 
observed, this may be due to the shared TDP-43 pathology 
between C9ORF72-positive and -negative AlS, which has 
been associated with er stress [68, 70]. In addition to our 
findings using human postmortem samples, it is also worth 
noting that a recent study reported that iPSC-derived motor 
neurons from c9AlS patient, which contain rNA foci and 
c9rAN proteins but no TDP-43 pathology [15], exhibit 
an increased vulnerability to tunicamycin [23], support-
ing the association between the C9ORF72 repeat expan-
sion and er stress. Future studies investigating whether, 
like poly(gA) proteins, rNA foci and other c9rAN pro-
teins inhibit proteasome activity and cause er stress are 
warranted.
er stress activation of the PerK–CHOP pathway is well 
documented (see [25, 67] for review). In brief, PerK is 
activated through auto-phosphorylation upon release from 
BIP. Upon activation, PerK phosphorylates eIF2α to atten-
uate global protein synthesis as a pro-survival mechanism. 
However, phosphorylation of eIF2α selectively allows the 
translation of ATF4 and CHOP, which induce cell death 
under prolonged er stress. This can occur through multi-
ple mechanisms that include expression of pro-apoptotic 
genes, promotion of protein synthesis, production of reac-
tive oxygen species (rOS) and ATP depletion [18, 24, 25, 
42, 51, 63]. For example, ATF4 and CHOP up-regulate 
levels of gADD34, which forms a complex with PP1C to 
dephosphorylate eIF2α; the dephosphorylation of eIF2α in 
turn enhances protein synthesis, ATP depletion and rOS 
production, which consequently induce cell death [24, 42]. 
The importance of this pathway is further validated by 
studies showing selective inhibitors of the gADD34–PP1C 
complex protect cells from er stress-induced cell death [9, 
66]. Consistent with these findings, we show that salubri-
nal, a selective inhibitor of the gADD34–PP1C complex 
[9, 36, 60], restored eIF2α phosphorylation, reduced er 
stress and increased cell survival in neurons expressing 
poly(gA) proteins. In addition, TUDCA, an inhibitor of 
er stress [13, 38, 52, 72], blocked the increase in phos-
pho-PerK and CHOP normally observed in poly(gA)-
expressing neurons, and provided neuroprotection against 
poly(gA)-induced toxicity. Of interest, the levels of 
poly(gA) and ubiquitinated proteins were not themselves 
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decreased after salubrinal and TUDCA treatment, suggest-
ing that proteasome inhibition, the culprit responsible for 
inducing er stress, remained present in these cells. This 
may explain why levels of BIP, which correlate with the 
amount of misfolded proteins in the er, were not altered 
following treatment of gFP-(gA)50-expressing cells with 
TUDCA. As a chemical chaperone, TUDCA may have 
bound to these misfolded proteins and caused the release 
of BIP, which then became free to interact with PerK and 
inhibit PerK auto-phosphorylation and activation. As a 
result, CHOP levels decreased as did caspase-3 activation. 
However, BIP levels remain unchanged because TUDCA 
did not eliminate the accumulation of misfolded proteins, 
but rather targeted downstream events only. Conversely, 
salubrinal treatment would have decreased protein trans-
lation by enhancing eIF2α phosphorylation, thus reduc-
ing the misfolded protein load in the er. Consequently, 
this would cause a decrease in levels of BIP and phospho-
PerK, and increase cell survival. That CHOP levels were 
not also decreased by salubrinal treatment may result from 
the increase in eIF2α phosphorylation, which regulates 
CHOP expression.
In summary, we have generated a novel poly(gA) anti-
body and confirmed that abundant poly(gA) neuronal 
inclusions are detected throughout the CNS of c9FTD/AlS 
cases. We show that poly(gA) proteins are highly aggre-
gation-prone and form filamentous structures in experi-
mental models and c9FTD/AlS brain tissue. Of particu-
lar importance, our data provide compelling evidence 
that poly(gA) proteins contribute to the neurodegenera-
tion in c9FTD/AlS. The expression of poly(gA) proteins 
causes neurotoxicity; this toxicity occurs in the absence of 
rNA foci, and is associated with impairment of the UPS 
and induction of er stress. er stress is believed to play 
an important role in several neurodegenerative diseases, 
including sporadic AlS [4, 26, 59, 69], and familiar AlS 
caused by mutations in Cu/Zn superoxide dismutase [8, 29, 
48, 55] or vesicle-associated membrane protein-associated 
protein B [27, 45, 62]. Our data extend the list of diseases 
involving er stress, and suggest that targeting the er, 
using small molecules such as salubrinal and TUDCA, may 
be a promising therapeutic approach for c9FTD/AlS.
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